Pyk2 promotes tumor progression and owes to a number of cancer‐related functional domains in structure: N‐terminal FERM domain, a central catalytic kinase domain, and C‐terminal focal adhesion targeting (FAT) domain (Lipinski and Loftus, 2010). Here, PTK2B is linked to cancer.